Applied BioMath applies mechanistic modeling to drug R&D to help biotechnology and pharmaceutical companies answer complex, scientific questions and make critical decisions for the advancement of drug candidates. A team of mathematicians, biologists, clinical pharmacologists and pharmaceutical industry experts, they leverage biology, mathematics, proprietary technologies, HPC, and industry experience to perform massive scale simulations which enable groups to determine best-in-class properties of a clinical candidate, reduce attrition rates, and identify key differentiators from competitors.
Ligand’s OmniAb® therapeutic antibody platforms produce highly diversified, fully human antibody repertoires optimized in vivo for manufacturability, therapeutic efficacy and reduced immunogenicity - Naturally optimized human antibodies®. The single-license OmniAb offering is the industry’s only with three species and multiple genetic backgrounds - 3 species, 1 license™
GenScript is the world leader in biotechnology, founded in 2002 and grown together with the synthetic biology industry and is now the world's leading gene synthesis supplier. Headquartered in New Jersey and with subsidiaries in Europe, Japan, and China. GenScript ProBio provides integrated & innovative biologics CDMO platform to accelerate the process from target to market and drive innovation further to develop therapeutic antibody and cell therapy platforms. We provide Antibody Discovery, Development services including plasmid and viral vectors. Our mission is making human and nature healthier through biotechnology.
FUJIFILM Diosynth Biotechnologies
FUJIFILM Diosynth Biotechnologies is an industry leading cGMP Contract Development and Manufacturing Organization (CDMO) supporting our partners in the biopharmaceutical industry with the development and production of their biologic, vaccines and gene therapies.
With more than three decade of experience in process development and cGMP manufacturing, a dedicated staff of over 3,000 and a reputation for excellent customer service, flexibility and responsiveness, we have become a trusted partner to some of the most prominent biotech developers and pharmaceutical companies in the industry.
Our Process Development experience includes the development of processes for molecules expressed via fermentation (e.g., E. coli, P. pastoris), cell culture systems including CHO, HEK, Vero, MDCK, EB66 and insect cells, and from transgenic sources.
Our network expands within four development and manufacturing facilities located in Teesside, United Kingdom; Research Triangle Park, North Carolina, USA; College Station, Texas, USA; and Hillerød, Denmark. Our organization is growing. In addition to our existing locations, we have upcoming facilities in Watertown, Massachusetts and Holly Springs, North Carolina.
Want to evaluate killing kinetics with physiologically relevant effector cell to target cell ratios? Concerned about the possible confounding effects of labeling your cells? Introducing Maestro ZHT from Axion BioSystems, the world’s most advanced impedance-based real-time cell analysis platform. Over minutes or weeks gain unprecedented access to the kinetics of your biology. Straightforward and easy to use, any researcher can now track immune cell-mediated killing in 96- and 384-well plates.
BSP Pharmaceuticals is a CDMO, technologically developed to meet needs of groundbreakers and specialized in manufacturing Oncology and Immunotherapy drug, including autoimmune disease, immunotherapy & CNS among others, with a specific focus on innovative compounds as small and large molecules.
With full containment facility, applying the most advanced and safe technologies, BSP can offer a wide range of services for Pre-Clinical, Clinical and Commercial supply in compliance with the highest Quality requirements.
GemPharmatech Co., Ltd. founded in 2017, is an international biotechnology enterprise specializing in the development of humanized animal models. The management and operation team have nearly 20 years’ experience in gene-editing technology and animal production. GemPharmatech provides a one-stop service as model customization, breeding, phenotyping, and pharmacology for the biomedical research community. The company has developed the world's most abundant mouse strains resource to inspire scientific innovation and drive drug discovery.
Asimov, the Boston-based synthetic biology company focused on mammalian cell engineering, recently launched our industry-leading platform for biologics production, with a focus on enabling expression of bispecific antibodies. Originally developed at MIT, our platform radically advances the design and manufacture of biologics and gene therapies. By integrating state-of-the-art genetic engineering, computational biology, and automation, Asimov enables breakthrough solutions to long-standing challenges in industry.